RFK Jr.’s Nomination for HHS Secretary Advances After Committee Hearings

On January 29, the Senate Finance Committee held a contentious hearing to evaluate the nomination of Robert F. Kennedy, Jr. as Secretary of the Department of Health and Human Services (HHS). The hearing underscored deep partisan divisions, with members of both parties questioning Kennedy’s positions on key health policy issues, including vaccines, Medicaid, and chronic disease prevention. While Republicans praised his emphasis on agency transparency and chronic disease management, Democrats expressed significant concerns over his past statements regarding vaccines, reproductive health, and Medicaid policy. 

A major focus of the hearing was Kennedy’s vision for the Medicaid program. He outlined broad reform objectives that aligned with the administration’s priorities, yet uncertainty remained about specific policy measures he would implement. Democrats pressed him on his past statements on vaccines, to which he responded by affirming his support for immunizations and pledging not to take actions that would discourage their use. However, skepticism remained, with several Democratic senators questioning whether his prior rhetoric could undermine public trust in vaccines and federal health agencies. 

The following day, the Senate Committee on Health, Education, Labor and Pensions (HELP) convened another hearing on Kennedy’s nomination, reiterating many of the concerns raised in the Finance Committee meeting. Senators engaged in pointed discussions on Medicaid and Medicare policy, vaccine safety, and public health preparedness. Although many Republicans backed Kennedy’s commitment to chronic disease prevention and individual choice in vaccine reception, several joined Democrats in expressing alarm over his past statements casting doubt on vaccine safety and the credibility of public health agencies. Both parties raised concerns that his history of questioning vaccine efficacy and federal health authorities could deepen public skepticism in government health initiatives, potentially leading to another public health crisis. 

In his closing remarks, Senate Finance Committee Chair Bill Cassidy (R-LA) signaled uncertainty over his support for Kennedy’s nomination, stating he had not yet decided how he would vote. However, on Tuesday, the Senate Finance Committee voted in favor of advancing Kennedy’s nomination to the Senate floor for a vote. The committee vote was 14-13, along party lines, with Sen. Cassidy voting in Kennedy’s favor. The next step in the confirmation process is a full vote in the Senate.